282 related articles for article (PubMed ID: 15476937)
1. Effects of urocortin 2 and 3 on motor activity and food intake in rats.
Ohata H; Shibasaki T
Peptides; 2004 Oct; 25(10):1703-9. PubMed ID: 15476937
[TBL] [Abstract][Full Text] [Related]
2. Human urocortin 2, a corticotropin-releasing factor (CRF)2 agonist, and ovine CRF, a CRF1 agonist, differentially alter feeding and motor activity.
Zorrilla EP; Reinhardt LE; Valdez GR; Inoue K; Rivier JE; Vale WW; Koob GF
J Pharmacol Exp Ther; 2004 Sep; 310(3):1027-34. PubMed ID: 15115804
[TBL] [Abstract][Full Text] [Related]
3. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
[TBL] [Abstract][Full Text] [Related]
4. Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells.
Kageyama K; Kimura R; Suga S; Ogawa Y; Suda T; Wakui M
Peptides; 2006 Jul; 27(7):1814-9. PubMed ID: 16513211
[TBL] [Abstract][Full Text] [Related]
5. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
6. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
Staub DR; Evans AK; Lowry CA
Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
[TBL] [Abstract][Full Text] [Related]
7. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system.
Hashimoto K; Nishiyama M; Tanaka Y; Noguchi T; Asaba K; Hossein PN; Nishioka T; Makino S
Peptides; 2004 Oct; 25(10):1711-21. PubMed ID: 15476938
[TBL] [Abstract][Full Text] [Related]
8. Urocortins and the regulation of gastrointestinal motor function and visceral pain.
Martinez V; Wang L; Million M; Rivier J; Taché Y
Peptides; 2004 Oct; 25(10):1733-44. PubMed ID: 15476940
[TBL] [Abstract][Full Text] [Related]
9. Mediation of burn-induced hypermetabolism by CRF receptor-2 activity.
Chance WT; Dayal R; Friend LA; Thomas I; Sheriff S
Life Sci; 2007 Feb; 80(11):1064-72. PubMed ID: 17222429
[TBL] [Abstract][Full Text] [Related]
10. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.
Smagin GN; Howell LA; Ryan DH; De Souza EB; Harris RB
Neuroreport; 1998 May; 9(7):1601-6. PubMed ID: 9631473
[TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice.
Tanaka M; Telegdy G
Brain Res Bull; 2008 Mar; 75(5):509-12. PubMed ID: 18355626
[TBL] [Abstract][Full Text] [Related]
12. Urocortin 2 acts centrally to delay gastric emptying through sympathetic pathways while CRF and urocortin 1 inhibitory actions are vagal dependent in rats.
Czimmer J; Million M; Taché Y
Am J Physiol Gastrointest Liver Physiol; 2006 Mar; 290(3):G511-8. PubMed ID: 16223946
[TBL] [Abstract][Full Text] [Related]
13. Endogenous expression and in vitro study of CRF-related peptides and CRF receptors in the rat gastric antrum.
Porcher C; Peinnequin A; Pellissier S; Meregnani J; Sinniger V; Canini F; Bonaz B
Peptides; 2006 Jun; 27(6):1464-75. PubMed ID: 16337313
[TBL] [Abstract][Full Text] [Related]
14. Stimulant and anxiogenic effects of corticotropin releasing factor.
Koob GF; Thatcher-Britton K
Prog Clin Biol Res; 1985; 192():499-506. PubMed ID: 3878524
[TBL] [Abstract][Full Text] [Related]
15. Effects of the traditional Japanese medicine Unkei-to on the corticotropin-releasing factor-induced increase in locomotor activity.
Terawaki K; Koike K; Yuzurihara M; Kase Y; Takeda S; Aburada M; Murakami K; Ohno S; Suzuki N; Inoue M
Pharmacol Biochem Behav; 2004 Aug; 78(4):799-803. PubMed ID: 15301938
[TBL] [Abstract][Full Text] [Related]
16. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval.
Fekete EM; Inoue K; Zhao Y; Rivier JE; Vale WW; Szücs A; Koob GF; Zorrilla EP
Neuropsychopharmacology; 2007 May; 32(5):1052-68. PubMed ID: 17019404
[TBL] [Abstract][Full Text] [Related]
17. Peripheral administration of CRF and urocortin: effects on food intake and the HPA axis in the marsupial Sminthopsis crassicaudata.
Hope PJ; Turnbull H; Farr S; Morley JE; Rice KC; Chrousos GP; Torpy DJ; Wittert GA
Peptides; 2000 May; 21(5):669-77. PubMed ID: 10876049
[TBL] [Abstract][Full Text] [Related]
18. Comparison of central administration of corticotropin-releasing hormone and urocortin on food intake, conditioned taste aversion, and c-Fos expression.
Benoit SC; Thiele TE; Heinrichs SC; Rushing PA; Blake KA; Steeley RJ
Peptides; 2000 Mar; 21(3):345-51. PubMed ID: 10793215
[TBL] [Abstract][Full Text] [Related]
19. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice.
Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW
Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of corticotropin-releasing factor effects on locomotion and foraging in the Western spadefoot toad (Spea hammondii).
Crespi EJ; Denver RJ
Horm Behav; 2004 Nov; 46(4):399-410. PubMed ID: 15465525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]